Caricamento quotazioni...

Previsioni

Acquista	1
Mantieni	0
Vendi	0

Notizie Vai al feed delle notizie

Haleon publishes latest figures on share capital and voting rights

Haleon has announced that as of July 31, 2025, the company has a total of 8,987,651,560 issued ordinary shares, of which 3,880,205 are held as treasury shares. The total number of shares with voting rights therefore amounts to 8,983,771,355. This information serves as the basis for calculations in accordance with the transparency requirements of the Financial Conduct Authority. » Altro su de.investing.com
Haleon appoints new members to committees

Haleon has appointed Bláthnaid Bergin to the audit and risk committee and Matt Shattock to the environmental and social sustainability committee. The appointments took immediate effect and were made in accordance with UK listing rules. The announcement was published by company secretary Amanda Mellor. » Altro su de.investing.com
Haleon stock delivers 12.16 percent return over three years

An investment of £1,000 in Haleon three years ago would be worth £1,121.64 today, representing an increase of 12.16 percent. The calculation does not account for stock splits or dividends. Haleon was first listed on the stock exchange in July 2022 and currently has a market capitalization of £31.87 billion. » Altro su finanzen.net

Dividendi storici Dividendi

Tutte le metriche sui dividendi Tutte le metriche

Nel 2026, Haleon PLC ha già distribuito 0,0842 € di dividendi. L'ultimo pagamento è avvenuto a settembre.

Dati finanziari dell'azienda

Nell'ultimo trimestre, Haleon PLC ha registrato ricavi pari a 3,19 Mld € e un utile netto di 469,43 Mln €

(EUR)	giugno 2025	YoY
Ricavi	3,19 Mld	-
Utile lordo	2,06 Mld	-
Utile netto	469,43 Mln	-
EBITDA	811,32 Mln	-

Dati fondamentali

Metrica	Valore
Capitalizzazione di mercato	34,29 Mld €
Numero di azioni	8,81 Mld
Massimo/minimo a 52 settimane	5,13 € - 3,71 €
Rendimento da dividendo	2,13%
Dividendi TTM	0,0842 €
Beta	0,24
Rapporto P/E	18,24
Rapporto PEG	3,10
Rapporto P/B	1,80
Rapporto P/S	2,61

Profilo aziendale

Haleon plc beschäftigt sich mit der Forschung und Entwicklung, der Herstellung und dem Verkauf verschiedener Produkte für die Gesundheitsvorsorge in Nordamerika, Europa, dem Nahen Osten, Afrika, Lateinamerika und dem asiatisch-pazifischen Raum. Das Unternehmen bietet therapeutische Produkte in den Bereichen Mundgesundheit, Schmerzlinderung, Atemwegsgesundheit, Verdauungsgesundheit und andere Produkte sowie Vitamine, Mineralien und Nahrungsergänzungsmittel an. Zu seinem Markenportfolio gehören Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax und Centrum. Das Unternehmen war früher unter dem Namen DRVW 2022 plc bekannt und änderte im Februar 2022 seinen Namen in Haleon plc. Haleon plc wurde im Jahr 2021 gegründet und hat seinen Hauptsitz in Brentford, Vereinigtes Königreich.

Nome	Haleon PLC
CEO	Brian James McNamara
Sede centrale	Weybridge, su Regno Unito
Sito web	haleon.com
Settore	Beni di prima necessità
Industria	Prodotti per la cura della persona
Quotazione in borsa	18/07/2022
Dipendenti	24.561